Skip to content

A Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services

A Randomized Study Of TeleGenetics Versus Usual Care To Increase Access To Cancer Genetic Services

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02517554
Enrollment
120
Registered
2015-08-07
Start date
2015-08-31
Completion date
2019-11-30
Last updated
2024-01-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer, Colorectal Cancer, Ovarian Cancer

Keywords

meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian and colorectal cancers

Brief summary

The goal of this research is to evaluate the relative advantage of remote counseling over usual care in community health practices without access to genetic services. We will evaluate ability of remote telemedicine, referred to going forward as TeleGenetic services (phone or videoconferencing), to increase uptake of genetic testing and identification of genetic carriers compared to usual care. Secondly, we will evaluate the advantages of videoconferencing over telephone for delivery of remote genetic services and the short-term and longitudinal outcomes of TeleGenetic services in socio-demographically diverse patients in community practices.

Interventions

BEHAVIORALPenn genetic counselors provides counseling and test results disclosure by videoconferene to patient at community site

Baseline and follow up survey

BEHAVIORALPenn genetic counselor provides counseling and test results disclosure by telephone to patient at community site

Baseline and follow up surveys

BEHAVIORALPatient receives written information on how to find genetic services in their area

Baseline and follow up surveys

Sponsors

Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Eligible participants will include adult men and women (aged 18 and older) who can understand and communicate in English 2. meet National Comprehensive Cancer Network® criteria for cancer genetic testing for breast, ovarian or colorectal cancers 3. have insurance coverage for genetic testing.

Exclusion criteria

1. Under 18 years old - professional guidelines do not recommend genetic testing for cancer risk in minors. 2. Does not speak English. 3. Does not have insurance.

Design outcomes

Primary

MeasureTime frame
Completion of Surveys3 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 24, 2026